Figure 3From: ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas ADAR2 expression levels in Cases 1–4. qRT-PCR analysis of ADAR2 mRNA from newly diagnosed (dark gray) and recurrent (light gray) tumors in Cases 1 to 4. The expression levels of each recurrence were calculated as a relative-fold increase compared to the corresponding newly diagnosed tumor arbitrarily set to 1. Each sample was normalized to β-actin mRNA. Mean ± s.d. (n=2), *p<0.05, **p<0.01.Back to article page